Bi­par­ti­san law­mak­ers pres­sure FDA on com­mon chemother­a­pies now in short­age

The US House of Rep­re­sen­ta­tives has turned a sharp eye to drug short­ages over the past few months, with hear­ings and new cau­cus­es to try and damp­en the sit­u­a­tion, but an­oth­er bi­par­ti­san let­ter sent yes­ter­day to FDA aims to keep the pres­sure up on can­cer drug short­ages.

Reps. Deb­bie Din­gell (D-MI) and Tim Wal­berg (R-MI) penned the let­ter to FDA Com­mis­sion­er Rob Califf, ex­press­ing con­cerns around the short­ages of two com­mon­ly used chemother­a­pies used to treat can­cer, known as cis­platin and car­bo­platin, which are used for lung, gy­ne­co­log­ic and breast can­cers, as well as methotrex­ate, which is used in treat­ing oth­er forms of can­cer.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER